Rapid response to ‘Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline’. BMJ. 2021 – https://doi.org/10.1136/bmj.n2040

Narouze SN, MacCallum CA. eds. Cannabinoids and Pain. Springer; 2021

Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process. Journal of Cannabis Research. 2021 – https://doi.org/10.1186/s42238-021-00073-1

Is medical cannabis safe for my patients?” A practical review of cannabis safety considerations. European Journal of Internal Medicine. 2021 – https://doi.org/10.1016/j.ejim.2021.05.002

Practical strategies using medical cannabis to reduce harms associated with long term opioid use in chronic pain. Frontiers in Pharmacology. 2021 – https://doi.org/10.3389/fphar.2021.633168

Duration of neurocognitive impairment with medical cannabis use: a scoping review. Frontiers in Psychiatry. 2021 – https://doi.org/10.3389/fpsyt.2021.638962

Guidance in Authorizing Cannabis Products Within Primary Care © 2021 The College of Family Physicians of Canada

Canadian clinical practice guidelines for the use of plant-based cannabis and cannabinoid-based products in the management of chronic non-cancer pain and co-occurring conditions: protocol for a systematic literature review. BMJ Open. 2020;10:e036114 – http://dx.doi.org/10.1136/bmjopen-2019-036114

Characterization of mental health in cannabis dispensary users, using structured clinical interviews and standardized assessment instruments. BMC Psychiatry. 2019;19:335 – https://doi.org/10.1186/s12888-019-2324-z

Practical considerations in medical cannabis administration and dosing. European Journal of Internal Medicine. 2018;49 – https://doi.org/10.1016/j.ejim.2018.01.004

.